BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1307918)

  • 1. Effect of a cholecystokinin antagonist, proglumide, on cholecystokinin-8-induced gallbladder contraction in conscious dogs.
    Fujimura M; Sakamoto T; Lluis F; Beauchamp RD; Townsend CM; Greeley GH; Thompson JC
    Biol Signals; 1992; 1(2):94-100. PubMed ID: 1307918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide YY and gallbladder contraction. Studies in vivo and in vitro.
    Lluis F; Fujimura M; Lonovics J; Guo YS; Gomez G; Greeley GH; Townsend CM; Thompson JC
    Gastroenterology; 1988 Jun; 94(6):1441-6. PubMed ID: 3360265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of two new cholecystokinin antagonists on gallbladder emptying in opossums.
    Hanyu N; Dodds WJ; Layman RD; Hogan WJ; Colton DG
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G258-64. PubMed ID: 1996645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N; Inui A; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of inhibitory action of peptide YY on cholecystokinin-induced contractions of isolated dog ileum.
    Baba H; Fujimura M; Toda N
    Regul Pept; 1990 Feb; 27(2):227-35. PubMed ID: 2326499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglumide antagonizes the stimulation of rabbit gallbladder by cholecystokinin.
    Kaplita PV; Roebuck BD
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):271-6. PubMed ID: 6476983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin antagonistic activities of loxiglumide.
    Wakatsuki K; Saito T; Saeki M; Ninomiya K; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1997 Oct; 47(10):1130-3. PubMed ID: 9368707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholecystokinin receptor antagonist loxiglumide: influence on bilio-pancreatic secretion and gastrointestinal hormones in man.
    Schmidt WE; Creutzfeldt W; Höcker M; Choudhury AR; Nustede R; Schleser A; Nitsche R; Rovati LC; Schafmayer A; Fölsch UR
    Digestion; 1990; 46 Suppl 2():232-9. PubMed ID: 2262057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of loxiglumide (CR-1505) on basal and bombesin-stimulated gallbladder volume in man.
    Douglas BR; Jebbink MC; Tjon a Tham RT; Jansen JB; Lamers CB
    Eur J Pharmacol; 1989 Jul; 166(2):307-9. PubMed ID: 2792196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of proglumide on cholecystokinin-8-induced exocrine and endocrine pancreatic responses in conscious sheep.
    Mineo H; Iwaki N; Kogishi K; Onaga T; Kato S; Zabielski R
    Comp Biochem Physiol A Physiol; 1997 Nov; 118(3):759-64. PubMed ID: 9406447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholecystokinin and cholinergic agents on periodic gallbladder contraction in dogs.
    Kondo T; Magee DF
    J Auton Pharmacol; 1990 Aug; 10(4):191-9. PubMed ID: 2229098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin stimulates neuronal receptors to produce contraction of the canine colon.
    Barone FC; Bondinell WE; Labosh TJ; White RF; Ormsbee HS
    Life Sci; 1989; 44(8):533-42. PubMed ID: 2927258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological effects of a proglumide derivative as cholecystokinin antagonist in conscious dogs.
    Hildebrand P; Beglinger C; Köhler E; Setnikar I; Gyr K
    Regul Pept; 1987 Aug; 18(3-4):213-20. PubMed ID: 3446223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK receptor antagonism by loxiglumide and gall bladder contractions in response to cholecystokinin, sham feeding and ordinary feeding in man.
    Konturek JW; Konturek SJ; Kurek A; Bogdal J; Oleksy J; Rovati L
    Gut; 1989 Aug; 30(8):1136-42. PubMed ID: 2767511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying.
    Gielkens HA; de Boer SY; Lam WF; Rovati LC; Lamers CB; Masclee AA
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1227-31. PubMed ID: 9471030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
    Romański KW
    J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of loxiglumide (CCK antagonist) inhibits postprandial gallbladder contraction without affecting gastric emptying.
    Corazziari E; Ricci R; Biliotti D; Bontempo I; De Medici A; Pallotta N; Torsoli A
    Dig Dis Sci; 1990 Jan; 35(1):50-4. PubMed ID: 2295294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide.
    Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.